Introduction
============

Salvinorin A (**1a**), isolated from the hallucinogenic sage *Salvia divinorum*,\[[@B1]\] is a potent and selective κ opioid receptor (KOR) agonist.\[[@B2]\] Because it is the first known non-nitrogenous compound to have biologically significant actions at mammalian opioid receptors, **1a**enables new approaches to studies of endogenous opioid receptor systems. KOR ligands, in particular, have attracted considerable interest because of their effects on mood states.\[[@B3]-[@B6]\] Recently, numerous synthetic derivatives of **1a**have been prepared and evaluated for activity at opioid receptors. Some potent agonists have been identified which are expected to show increased stability or solubility.\[[@B7]\] Others have increased affinity and potency, \[[@B8]\] or altered subtype selectivity.\[[@B9]\] As yet, however, no derivatives of **1a**appear to be KOR partial agonists or antagonists, classes of agents that may have utility in the treatment of psychiatric conditions such as depression or mania.\[[@B4],[@B5],[@B10]\]
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Salvinorins tend to isomerize under basic conditions. Valdés reported that borohydride reduction of **1a**gave an unidentified stereoisomeric byproduct, which could be converted to an undetermined stereoisomer of **1a**.\[[@B11]\] The latter compound was subsequently identified by Brown as 8-*epi*-salvinorin A (**1b**).\[[@B12]\] Brown also reported that deacetylation of **1a**under basic conditions gave 8-*epi*-salvinorin B (**2b**), but did not characterize either compound. Several further reports of epimerization at C-8 appeared over the following decade, \[[@B13],[@B14]\] but no characterization data was presented. Valdés later identified the byproduct mentioned above as 8-*epi*-diol **3**.\[[@B15]\] Characterization data was given, but the basis of the structure assignment was not stated.
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The first structure elucidation of one of these compounds was of 8-*epi*-salvinorin A (**1b**).\[[@B16]\] The *trans*-diaxial H-8 coupling constant found in **1a**was absent in **1b**, establishing an equatorial configuration. Also, irradiation of H-12 in **1b**gave a strong nOe enhancement of H-8. The corresponding experiment on **1a**gave instead an enhancement of H-20. These findings can be extrapolated to **2b**, since acetylation gives **1b**quantitatively.\[[@B9],[@B17]\] Conflicting ^1^H NMR data for **2b**itself were later reported by two groups.\[[@B8],[@B9]\] The ^1^H NMR spectrum of **2b**is reproduced in [Additional file 1](#S1){ref-type="supplementary-material"}; the corresponding amended data have been reported previously.\[[@B17]\] Interestingly, epimerization has also recently been reported under acidic conditions.\[[@B18]\]

The epimers can be readily identified by TLC: the unnatural compounds almost invariably spot above the natural compounds in EtOAc/hexanes, and give a blue rather than pink/purple colour when visualized with vanillin.\[[@B19]\] The unnatural epimers are also recognizable by their distinctive H-12 multiplet in ^1^H NMR, which resembles a broad doublet shifted upfield to \~δ 5.30 ppm. Many 8-*epi*-salvinorin derivatives have now been reported, although many have not been fully characterized.\[[@B7]-[@B9],[@B17],[@B18],[@B20]-[@B24]\] Thus, the many reports of 8-*epi*-salvinorins and derivatives have been based on limited data.

Results and Discussion
======================

The crystal structure presented here (Figure [1](#F1){ref-type="fig"}) is the first reported for an 8-*epi*-salvinorin or derivative. It firmly establishes the structure of **2b**, and therefore of **1b**. The lactone carbonyl C-17 is axial with respect to the B ring (C6-7-8-17 torsion angle 77° versus 173° in **1a**).\[[@B1]\] The lactone itself adopts a boat conformation with the furan equatorial (C9-11-12-13 torsion angle 179°). This is as predicted in solution, on the basis of a *trans*-diaxial coupling constant for H-12.\[[@B17]\] This is also consistent with the crystal structures of furanolactones with all other possible C8/9/12 stereochemistries (*trans/anti*, *trans/syn*and *cis/syn*) -- the furan is equatorial in all cases.\[[@B17]\] The rest of the structure is very similar to the crystal structure of **1a**.\[[@B1]\] The hydroxyl group participates in an intramolecular hydrogen bond with the ketone (O2-H2···O1, 2.12 Å). There are no intermolecular hydrogen bonds. The asymmetric unit consists of two molecules; the only substantial difference between them is in the rotation of the furan ring (C11-12-13-14 torsion angle -87° (A) versus 53° (B)). The crystals are monoclinic, space group *P*2~1~(see Figure [2](#F2){ref-type="fig"}). The crystallographic data can be found in [Additional file 2](#S2){ref-type="supplementary-material"}; the structure factors are in [Additional file 3](#S3){ref-type="supplementary-material"}. The crystallographic data have also been deposited with the Cambridge Crystallographic Data Centre (CCDC 626179).\[[@B25]\] 8-*epi*-Salvinorins and derivatives have a much weaker tendency to crystallize than their natural counterparts. Unsurprisingly, therefore, **2b**has a lower melting point (192--196°C) than **2a**(239--240°C).\[[@B17]\]

![Stereoview of the molecular structure of **2b**, showing 50% probability displacement ellipsoids and the atom-numbering scheme. Only one of the two molecules in the asymmetric unit is shown.](1860-5397-3-1-1){#F1}
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Configuration at C-8 is biologically significant. The affinity and potency of 8-*epi*-salvinorin A (**1b**) at the KOR are dramatically lower than those of **1a**.\[[@B16]\] This finding has been replicated several times.\[[@B8],[@B9],[@B20]\] The same trend is evident with many salvinorin derivatives: epimerization of active compounds at C-8 reduces affinity and potency.\[[@B8],[@B9],[@B20],[@B23],[@B24]\] Very few exceptions to this trend have been reported to date.\[[@B8],[@B23]\] These include 8-*epi*-salvinorin B (**2b**) itself, whose binding affinity (*K*~i~= 43 nM) was reportedly greater than that of the natural epimer **2a**(111 nM).\[[@B8]\] To explore this anomaly, we submitted a new sample of **2b**for *in vitro*testing at the KOR. Binding affinity, potency and efficacy were determined as previously described (Table [1](#T1){ref-type="table"}).\[[@B26]\]

###### 

Affinities (*K*~i~), potencies (EC~50~), and efficacies at the KOR.

  Compound   *K*~i~± SEM ^a,b^   EC~50~± SEM^b,c^   *E*~max~ ± SEM^d^
  ---------- ------------------- ------------------ -------------------
  **1a**     2.4 ± 0.4           1.8 ± 0.5          98 ± 3
  **2b**     304 ± 46            214 ± 33           90 ± 2
  **4a**     \>10,000            \-                 \-
  **4b**     \>10,000            \-                 \-
  U50,488H   2.2 ± 0.3           1.4 ± 0.3          100

^a^Inhibition of \[^3^H\]diprenorphine binding to membranes of Chinese hamster ovary cells stably transfected with the human KOR (CHO-hKOR). ^b^Mean ± SEM of three independent experiments performed in duplicate. ^c^Enhancement of \[^35^S\]GTPγS binding to CHO-hKOR membranes. ^d^Relative to that of U50,488H control.

The binding affinity of **2b**(*K*~i~= 304 nM) was lower than those previously reported for salvinorin B (**2a**) under the same conditions (66, 111 or 155 nM).\[[@B7],[@B8],[@B27]\] An early report that **2a**was inactive employed a different radiolabeled ligand, \[^3^H\]bremazocine.\[[@B28]\] Subsequent testing with \[^3^H\]diprenorphine by the same group gave concordant values for the relative affinity of **2a**.\[[@B17]\] Thus, our data suggest that **2b**in fact has a lower affinity than **2a**, consistent with the general trend mentioned above. We also reexamined the epimeric acids **4**.\[[@B16]\] In a previous report, **4a**was found to be inactive (*K*~i~\> 1,000 nM), but the 8-epimer **4b**showed high affinity at the KOR (49 nM).\[[@B23]\] In contrast, our current samples of both **4a**and **4b**showed no affinity at the KOR (Table [1](#T1){ref-type="table"}).

Given the very high binding affinity of **1a**, contamination of an inactive or weakly active compound with even traces of **1a**will cause large errors. Flash chromatography in EtOAc/hexanes effectively separates **2b**from **2a**, but not from **1a**. To overcome this, we re-chromatographed our sample in acetone/CH~2~Cl~2~, which resolves **2b**from **1a**, and verified purity by ^1^H NMR \[[Additional file 1](#S1){ref-type="supplementary-material"}\]. No methoxy peak corresponding to **1a**(δ 3.72) was apparent above baseline noise. We separated **4a**and **4b**with difficulty by repeated chromatography in EtOAc/hexanes. The sample of **4a**contained traces of an inseparable impurity, which if active might artificially elevate the apparent binding affinity. Since the sample showed no affinity, however, this problem does not arise. The ^1^H NMR spectra are reproduced in [Additional data file 1](#S1){ref-type="supplementary-material"}.

There is no consensus on the mechanism of base-catalyzed epimerization at C-8. Koreeda and coworkers proposed a complex mechanism, initiated by ketone enolate formation. The configuration of H-8 is inverted indirectly, without exchange, by cleavage of the C-8/9 bond (see Scheme [1](#C1){ref-type="fig"}). \[[@B11]-[@B13]\] The simpler mechanism of enolization of the lactone itself has also been proposed.\[[@B16]\] A detailed case for this mechanism has been presented, giving evidence that H-8 exchanges under mildly basic conditions, and that similar furanolactones lacking the ketone also undergo epimerization.\[[@B17]\] Other workers remain undecided.\[[@B8],[@B18]\]

![Koreeda *et al\'s*proposed mechanism for the epimerization.](1860-5397-3-1-i1){#C1}
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###### Additional File 1

Experimental details; statement of author contributions; ^1^H NMR spectra of **2b, 4a**and **4b**(Portable Document Format).
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###### Additional File 2

Crystal structure of **2b**(Crystallographic Information File).
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###### Additional File 3

Structure factors for **2b**(Crystallographic Information File).
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